STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCYT
  4. [Form 4] VERACYTE, INC. Insider Trading Activity

Veracyte (VCYT) EVP records 3,176-share sale and tax withholding moves

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Veracyte EVP and General Counsel Annie McGuire reported recent share transactions in Veracyte, Inc. common stock. On June 4, 2026, she completed open-market sales of 3,176 shares in total, consisting of 1,776 shares at a weighted average price of $50.1168 per share and 1,400 shares at a weighted average price of $49.3061 per share. These sales were made pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 29, 2025. Following these sales, she directly held 137,240 shares of Veracyte common stock. On June 2, 2026, 3,292 shares were withheld at $47.80 per share to satisfy tax withholding obligations upon vesting of restricted stock units, which the company notes did not represent a market sale.

Positive

  • None.

Negative

  • None.
Insider McGuire Annie
Role EVP, General Counsel
Sold 3,176 shs ($158K)
Type Security Shares Price Value
Sale Common Stock 1,400 $49.3061 $69K
Sale Common Stock 1,776 $50.1168 $89K
Exercise Price or Tax Liability Common Stock 3,292 $47.80 $157K
Holdings After Transaction: Common Stock — 137,240 shares (Direct)
Footnotes (4)
  1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.
  2. F2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
  3. F3. Represents weighted average sales price. Sale prices for the transactions range from $48.84 to $49.84. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  4. F4. Represents weighted average sales price. Sale prices for the transactions range from $49.89 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Open-market sale 1 1,776 shares at $50.1168/share Common Stock sale on June 4, 2026
Open-market sale 2 1,400 shares at $49.3061/share Common Stock sale on June 4, 2026
Tax withholding shares 3,292 shares at $47.80/share Withheld for RSU tax obligations on June 2, 2026
Total shares sold 3,176 shares Net open-market sales reported on Form 4
Shares held after transactions 137,240 shares Direct holdings after June 4, 2026 sales
Rule 10b5-1 plan adoption date August 29, 2025 Plan governing reported trades
Rule 10b5-1 plan regulatory
"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
restricted stock units financial
"in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units"
weighted average sales price financial
"Represents weighted average sales price. Sale prices for the transactions range from $48.84 to $49.84."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Veracyte (VCYT) EVP Annie McGuire report?
Annie McGuire reported open-market sales of 3,176 Veracyte shares on June 4, 2026. In addition, 3,292 shares were withheld on June 2, 2026 to cover tax obligations from restricted stock unit vesting, which the company specifies did not represent a sale.

At what prices were the Veracyte (VCYT) shares sold by the EVP?
The reported Veracyte share sales used weighted average prices of $49.3061 and $50.1168 per share. Actual sale prices ranged from $48.84 to $50.40, with detailed breakdowns available to regulators, the company or shareholders upon request, according to the disclosure footnotes.

How many Veracyte (VCYT) shares does the EVP hold after these transactions?
After the reported transactions, Annie McGuire directly holds 137,240 shares of Veracyte common stock. This figure reflects the impact of both the June 2, 2026 tax withholding related to restricted stock units and the June 4, 2026 open-market sales detailed in the filing.

Were the Veracyte (VCYT) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states that the transactions on this Form 4 were made pursuant to a Rule 10b5-1 trading plan. The plan was adopted by the reporting person on August 29, 2025, indicating the trades were pre-arranged rather than discretionary at the time of execution.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGuire Annie
(Last)(First)(Middle)
6000 SHORELINE COURT, SUITE 300
(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026F(1)3,292D$47.8140,416D
Common Stock06/04/2026S(2)1,400D$49.3061(3)139,016D
Common Stock06/04/2026S(2)1,776D$50.1168(4)137,240D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.
2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
3. Represents weighted average sales price. Sale prices for the transactions range from $48.84 to $49.84. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
4. Represents weighted average sales price. Sale prices for the transactions range from $49.89 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Remarks:
/s/ Jonathan Wygant, as attorney-in-fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR